期刊文献+

安颤灵对蛋白酶体抑制剂lactacystin诱导PC12细胞凋亡的影响 被引量:1

Effects of Anchanling on Apoptosis Induced by Proteasome Inhibitor Lactacystin in PC12 Cells
下载PDF
导出
摘要 观察安颤灵含药血清对lactacystin诱导PC 12细胞凋亡的影响。方法:按照血清药理学实验方法制备安颤灵含药血清,采用lactacystin作用于PC 12细胞,建立泛素-蛋白酶体系统损伤的细胞模型。将含药血清分为大、中、小剂量组,MTT方法检测各组的细胞活力;将对数生长期的PC 12细胞分为正常组、lactacystin组(损伤组)、中药组,通过Tunel及免疫细胞化学方法,观察各组细胞凋亡情况。结果:与大、小剂量组相比,中剂量组细胞的存活率显著升高(P<0.01);与正常组相比,lactacystin组细胞凋亡指数明显增加(P<0.01);与lactacystin组相比,中药组细胞凋亡指数明显降低(P<0.01)。结论:安颤灵含药血清具有抗lactacystin诱导的细胞凋亡作用。 Objective To explore the effects of Anchanling on lactacystin inducing apoptosis in PC 12 cells. Methods Serum pharmacological method was used to prepare serum containing Anchanling. Lactacystin was used as proteasome inhibitor to create a cellular model of ubiquitin-proteasome system dysfunction in PC 12 cells. PC 12 cells were divided into three groups:lactacystin treated group, Anchanling treated group and control group. We used MTT assay to evaluate cellular viability. TUNEL staining was employed to observe the apoptosis of nervec cells. Results The AnChanLing middle dose group showed the highest cellular viability of the three dose group(P 〈 0.01). Compared to the control group, the proportion of apoptosis in lactacystin group was increased significantly(P 〈 0.01). The proportion of apoptosis in Chinese medicine trated group were significantly lower than thet of lactacystin treated group(P 〈 0.01). Conclusion AnchanLing could obviously lower the neurotoxicity induced by lactacystin in PC 12 cells, which maybe relate to inhibiting the apoptosis of PC 12 cells.
出处 《深圳中西医结合杂志》 2009年第6期329-332,共4页 Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
基金 国家自然科学基金资助项目(30772757)
关键词 帕金森病 安颤灵 中药药理 泛素-蛋白酶体系统 细胞凋亡 Parkinson' disease AnChanLing Chinese medicine pharmacology Ubiquitin proteasome system Apoptosis
  • 相关文献

参考文献6

二级参考文献27

  • 1[1]Olanow CW.Genetics of Parkinson's disease[J].J Neurol,2001,248(10):833-840.
  • 2[2]Recchia A,Debetto P,Negro A,et al.α-synuclein and Parkinson's disease[J].FASEB J,2004,18(6):617-626.
  • 3[3]McNaught KS,Olanow CW.Proteolytic stress:A unifying concept for the etiopathogenesis of Parkinson's disease[J].Ann Neurol,2003,53(Suppl 3):73-86.
  • 4[4]McNaught KS,Olanow CW,Halliwell B,et al.Failure of ubiquitin-proteasome system in Parkinson's disease[J].Nat Rev Neurosci,2001,2(8):589-594.
  • 5[5]McNaught KS,Jenner P.Proteasome function is impaired in substantia nigra in Parkinson's disease[J].Neurosci Lett,2001,297(3):191-194.
  • 6[6]McNaught KS,Belezaire R,Isacson O,et al.Altered proteasomal function in Parkinson's disease[J].Exp Neurol,2003,179 (1):38-46.
  • 7[7]Nam S,Smith DM,Dou QP.Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo[J].J Biol Chem,2001,276(16):13322-13330.
  • 8[8]Fornai F,Lenzi P,Gesi M,et al.Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition[J].J Neurosci,2003,23 (26):8955-8968.
  • 9[9]McNaught KS,Mytilineou C,Jnobaptiste R,et al.Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures[J].J Neurochem,2002,81(2):301-306.
  • 10[10]Conway KA,Rochet iC,Bieganski RM,et al.Kinetic stabilization of the α-synuclein protobril by a dopamine-α-synuclein adduct[J].Science,2001,294(9):1346-1349.

共引文献10

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部